One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Quest for the holy grail: biomarkers in SLE
doi : 10.1016/S2665-9913(22)00362-9
Volume 5, Issue 1, January 2023, Page e1
Ustekinumab with or without methotrexate for psoriatic arthritis?
Charlotte E Gollins a b, William Tillett a b
Molecular signature-based decision making in the era of targeted therapies for systemic lupus erythematosus
doi : 10.1016/S2665-9913(22)00358-7
Volume 5, Issue 1, January 2023, Pages e4-e6
Whole-body MRI for juvenile idiopathic arthritis
Coziana Ciurtin a b, Timothy Bray c, Varvara Choida a b, Margaret A Hall-Craggs c
Better diagnostic tools needed for biopsy-negative giant cell arteritis
Victor Yang a, Christopher McMaster a b d, Claire E Owen a e, Jessica L Y Leung a e, Bonnia Liu a c, Russell R C Buchanan a e, David F L Liew a b e
Correction to Lancet Rheumatol 2022; 4: e853–63
doi : 10.1016/S2665-9913(22)00357-5
Volume 5, Issue 1, January 2023, Page e11
Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial
Michaela Koehm MD a, Tanja Rossmanith PhD b, Ann C Foldenauer PhD b, Prof Eva Herrmann PhD c, Jan Brandt-Jürgens MD d, Prof Gerd R Burmester MD e, Prof Herbert Kellner MD f, Uta Kiltz MD g h, David M Kofler MD i, Jürgen Rech MD j, Sorwe Mojtahed-Poor MD a, Christin Jonetzko b, Prof Harald Burkhardt MD a, Prof Frank Behrens MD a
Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial
doi : 10.1016/S2665-9913(22)00332-0
Volume 5, Issue 1, January 2023, Pages e24-e35
Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study
doi : 10.1016/S2665-9913(22)00330-7
Volume 5, Issue 1, January 2023, Pages e36-e46
Role of neutrophil interleukin-23 in spondyloarthropathy spectrum disorders
Tom Macleod PhD a, Charles Bridgewood PhD a, Prof Dennis McGonagle MD a b
Sudden onset blurred vision with visual floaters in a 51-year-old man
doi : 10.1016/S2665-9913(21)00285-X
Volume 5, Issue 1, January 2023, Page e58
